Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q9ULZ9
UPID:
MMP17_HUMAN
Alternative names:
Membrane-type matrix metalloproteinase 4; Membrane-type-4 matrix metalloproteinase
Alternative UPACC:
Q9ULZ9; Q14850
Background:
Matrix metalloproteinase-17 (MMP-17), also known as Membrane-type matrix metalloproteinase 4, plays a crucial role in degrading extracellular matrix components like fibrin. It activates precursors of growth factors and inflammatory mediators, including tumor necrosis factor-alpha, and is implicated in tumor processes. MMP-17's specificity excludes collagen types I-V, gelatin, fibronectin, laminin, decorin, and alpha1-antitrypsin.
Therapeutic significance:
Understanding the role of Matrix metalloproteinase-17 could open doors to potential therapeutic strategies.